Cytomegalovirus Immune Globulin Intravenous Human Articles

Australia's CSL to up R&D expenditure

2 April 2007

ZLB buys MedImmune's CytoGam for $50M

22 December 2006

MedImmune sells CytoGam to ZLB Behring

13 November 2006

MedImmune's 2nd-qtr plunges into loss

2 August 2004

MedImmune's CytoGam Cleared In Canada

7 August 1997

US Biopharma Firms See Research Bear Fruit In '96

17 February 1997

Biopharmaceutical Firms Report On 2nd Qtr

12 August 1996

Clinical Progress For US Biopharma Firms In 1st Qtr

6 May 1996

Important Developments For US Biotechnology Cos

19 February 1996

RespiGam Licensed In First Market

29 January 1996

MEDIMMUNE APPROVAL

24 January 1994

BAD NEW FOR MEDIMMUNE AS RESPIGAM STUMBLES

13 December 1993

BIOTECH PRODUCTS INUS DEVELOPMENT

26 July 1993

Showing 1-13 of 13 articles

Go to beginningPrevious
  • 1
NextGo to end